|
Real-time
OTC Markets
10:30:58 2026-06-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.0711 USD | -15.16% |
|
+29.27% | +16.08% |
| 08-12 | Radnostix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-24 | Radnostix, Inc. acquired Certain Assets of Lucerno Dynamics, LLC for 1.65 million. | CI |
| Market Cap | 30.18M 26.01M 24.62M 22.32M 41.87M 2.88B 42.08M 292M 112M 1.47B 113M 111M 4.64B | P/E 2024 |
2,150x | P/E 2025 | -35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 37.39M 32.21M 30.5M 27.65M 51.87M 3.57B 52.13M 362M 139M 1.82B 140M 137M 5.74B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 3.03x |
| Free-Float |
26.54% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -15.16% | ||
| 1 week | +29.27% | ||
| Current month | +18.50% | ||
| 1 month | +4.56% | ||
| 3 months | -7.54% | ||
| Current year | +16.08% |
| 1 week | 0.05 |  | 0.08 |
| 1 month | 0.05 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.11 |
| 3 years | 0.02 | | 0.11 |
| 5 years | 0.02 | | 0.12 |
| 10 years | 0 | | 0.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shahe Bagerdjian
CEO | Chief Executive Officer | 42 | 2023-08-31 |
W. Cox
DFI | Director of Finance/CFO | 42 | 2019-09-29 |
John Miller
LAW | General Counsel | 61 | 2000-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Laflin
BRD | Director/Board Member | 69 | 2001-05-31 |
| Chairman | 58 | 2017-06-30 | |
Robert Atcher
BRD | Director/Board Member | 74 | 2017-08-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/25 | Free | Director | 250,000 | 0.0478% | ||
| 10/10/25 | Free | Chairman | 500,000 | 0.0955% | ||
| 10/10/25 | Free | Director | 500,000 | 0.0955% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.16% | +29.27% | +14.68% | +55.24% | 30.18M | |
| +0.32% | -8.27% | +15.24% | -82.57% | 2.17B | |
| -0.14% | -6.46% | -54.17% | -64.87% | 1.42B | |
| -0.10% | -0.83% | -21.45% | -10.02% | 357M | |
| +0.23% | -2.84% | -48.49% | - | 52.64M | |
| Average | -3.00% | -11.84% | -18.84% | -25.55% | 804.59M | |
| Weighted average by Cap. | -0.06% | -22.05% | -13.28% | -68.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.9M 11.98M 11.34M 10.28M 19.28M 1.33B 19.38M 135M 51.79M 676M 52.2M 51.06M 2.13B | 13.07M 11.26M 10.66M 9.66M 18.13M 1.25B 18.22M 127M 48.7M 635M 49.09M 48.01M 2.01B |
| Net income | 8.57K 7.39K 6.99K 6.34K 11.89K 819K 11.95K 83.08K 31.95K 417K 32.2K 31.49K 1.32M | -908K -782K -741K -671K -1.26M -86.75M -1.27M -8.8M -3.38M -44.13M -3.41M -3.34M -139M |
| Net Debt | 6.42M 5.53M 5.23M 4.74M 8.9M 613M 8.95M 62.17M 23.91M 312M 24.1M 23.57M 985M | 7.21M 6.21M 5.88M 5.33M 10M 688M 10.05M 69.82M 26.85M 350M 27.06M 26.47M 1.11B |
Employees
45
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | US$0.0570 | -3.65% | 1,351 |
| 26-09-08 | US$0.0592 | +7.64% | 90,329 |
| 26-09-02 | US$0.0550 | +1.85% | 3,144 |
- Stock Market
- Stocks
- INIS Stock
Select your edition
All financial news and data tailored to specific country editions
